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We have generated doubly transgenic (DT) mice that independently express cDNA genes for the nucleocapsid protein
(NP) and the surface glycoproteins (GP) of lymphocytic choriomeningitis virus (LCMV). By RT-PCR, transcription of both
transgenes was detected at low levels in brain and kidney but was not observed in the thymus. Additionally, transcription
of the GP transgene was observed in the spleen. Following challenge with exogenous LCMV, an anti-NP CTL response was
induced in LCMV-infected DT mice, suggesting that nonresponsiveness to NP had not been established. In contrast, LCMV-
infected DT mice were nonresponsive to GP and failed to mount any CTL response against GP, either at Day 7 or Day 30
postinfection or following expansion of splenocyte populations in vitro. A significant number (33%) of adult DT mice survived
intracerebral infection with LCMV, suggesting that virus-induced immunopathology in the central nervous system can be
diminished by combined expression of the transgenes whereas no protective effect was conferred on singly transgenic
mice, expressing NP or GP alone. The DT mice therefore create a novel host genetic background for comparative studies
of the anti-LCMV immune responses relative to parental C57Bl/6 mice. q 1997 Academic Press
INTRODUCTION All previous LCMV transgenic mouse studies have
been performed with individual LCMV cDNA genes en-
Infections of mice with lymphocytic choriomeningitis coding either NP or GP-C. However, in order to look
virus (LCMV) have been studied for more than 60 years simultaneously at CTL responses to both NP and GP, we
as reproducible and manipulable models for virus– host produced mice that express NP and GP-C transgenes
interactions (reviewed in Salvato, 1993; Asano and (doubly transgenic, DT, mice) from independently regu-
Ahmed, 1995; Southern, 1996). The LCMV model is partic- lated transcription units. By breeding the DT mice back
ularly noted for rapid induction of potent anti-LCMV CTL onto the H-2b background, we have contrived to ensure
responses that, according to the circumstances of infec- that defined immunodominant epitopes within both NP
tion, can cause lethal choriomeningitis or effectively clear and GP-C are presented appropriately for potential rec-
infectious virus (Cole et al., 1972; Byrne and Oldstone, ognition by anti-LCMV-specific CTLs (Whitton et al.,
1984). In recent years, transgenic mouse technology (re- 1988b). In this report, we compare the outcome of acute
viewed by Hanahan, 1989) has been used to express LCMV infections and the character of the anti-LCMV
LCMV cDNA genes for the major structural proteins (NP, CD8/ T-cell response in adult DT mice and control
the internal nucleocapsid protein, or GP-C, the precursor C57Bl/6 mice.
for the mature surface glycoproteins) to determine
whether the normal course of LCMV infection and/or host MATERIALS AND METHODS
immune responses to LCMV infection are modified in
Cell linesthe context of a genetically altered mouse. When the rat
insulin promoter was used to target LCMV GP transgene EL4. A thymoma cell line derived from C57Bl/6 mice
expression in the b islet cells of the pancreas, the (kindly provided by Dr. Steve Jameson, University of Min-
transgenic mice were either nonresponsive to GP (Old- nesota).
stone et al., 1991) or immunologically ignorant of GP MC57G. A methylcholanthrene-induced fibroblast cell
(Ohashi et al., 1991). However, in both systems, an anti- line from C57Bl/6 mice. Both cell lines were propagated
LCMV-specific CTL response could be induced in the in RPMI 1640 supplemented with 10% heat-inactivated
transgenic mice, by exogenous LCMV infection, that re- FCS, 2 mM L-glutamine, and antibiotics (RP10 medium).
sulted in cellular infiltration and destruction of the pan-
creatic islets (Oldstone et al., 1991; Ohashi et al., 1991). Mice
C57Bl/6 mice were purchased from Charles River (Wil-
mington, MA) and were used at 6– 12 weeks of age for1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (612) 626-0623. breeding and as controls in experiments. Mice were in-
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fected with the Armstrong strain of LCMV (clone 53b; RNA using the PolyATtract mRNA magnetic particle isola-
tion system (Promega, Madison, WI).Dutko and Oldstone, 1983), either by intraperitoneal in-
jection of 5 1 105 PFU or by intracerebral injection of 1
RT/PCR amplifications1 102 PFU.
Tissue mRNA samples were treated with 1 unit of am-
Tissue preparation for histology plification grade DNase I (Gibco BRL, Gaithersburg, MD)
for 15 min at room temperature and then heated at 657CTissues were fixed in 10% neutral buffered formalin,
for 10 min. The DNase I-treated mRNAs were mixed withembedded in paraffin, and 3-mm sections were stained
500 ng of random hexanucleotide primer, heated to 707Cby the periodic acid-Schiff method (PAS).
for 10 min, and then annealed by slow cooling to room
temperature. The annealed samples were incubated inGeneration of transgenic mice
a 40-ml reaction cocktail with each deoxyribonucleoside
LCMV NP and GP-C singly transgenic mice were gen- triphosphate at 0.25 mM, 25 units RNase inhibitor (Pro-
erated at Scripps Research Institute using standard mega, Madison, WI), 0.1 M Tris – HCl (pH 8.3), 140 mM
transgenic procedures and reconstructed cDNA genes KCl, 10 mM MgCl2 , and 15 U of AMV reverse tran-
for NP and GP-C (Hogan et al., 1986; Southern et al., scriptase (Boehringer Mannheim) for 1 hr at 427C. The
1987; Oldstone et al., 1991). Founder mice, shown to reactions were stopped by heating for 5 min in a boiling
have integrated copies of the transgene, were crossed water bath and chilling on ice.
to C57Bl/6 mice to establish singly transgenic lines. The PCR amplification of cDNAs was performed in sepa-
singly transgenic mice were cross-bred at the University rate reactions containing 100 ng each of unique 5* and
of Minnesota to generate mice carrying both transgenes 3* oligodeoxynucleotide primers. The NP primers were
(DT mice) and DT mice were maintained by sequential NP2 (5* GTG CAG AAG AAC TGA TGT TCT 3*) and NP8
matings with C57Bl/6 mice. The NP and GP-C transgenes (5* AGA ACT GCC TTC AAG AGG TCC T 3*). The GP
were transmitted as unlinked Mendelian markers and primers were GP1 (5* CTC TAG ATC AAC TGG GTG TCA
the genotype of all progeny mice was established experi- G 3*) and GP3 (5* CAG CCA CTC CTC ATG TAT TTT CC
mentally. NP and GP singly transgenic mice, produced 3*). Five microliters of each cDNA product was incubated
at each DT 1 C57Bl/6 mating were used extensively as with the primers and 1.5 units of Taq DNA polymerase
controls in these experiments. (Boehringer Mannheim) in a buffer containing 10 mM
Tris – HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2 , 0.001%Genotyping of transgenic mice gelatin, and each deoxyribonucleoside triphosphate at
50 mM. The reaction mixtures were then amplifiedTail DNA samples were screened by hybridization us-
through 40 cycles at 607C for 1 min, 727C for 2 min, anding LCMV-specific GP and NP probes (Southern et al.,
947C for 1 min, followed by final incubations at 607C for1987). Alternatively, screening was performed by PCR
1 min, and 727C for 10 min. The PCR amplifications wereusing DNA extracted from pieces of ear. The tissue was
carried out in an automated thermal cycler (Perkin –El-added to 20 ml of 50 mM Tris – HCl (pH 8.0), 2 mM NaCl,
mer – Cetus, Emeryville, CA). Reaction products were an-10 mM EDTA, 1% SDS, and 1 ml of 20 mg/ml proteinase
alyzed by agarose gel electrophoresis then DNA withinK (Boehringer-Mannheim, Indianapolis, IN) and incu-
the gel was transferred to nylon membranes for hybrid-bated at 557C for 15 min. After vigorous vortexing, the
ization with NP or GP-C region-specific probes (Southernproteinase K digestion was repeated with an additional
et al., 1987).20 ml of buffer. Sterile water was then added to a final
volume of 200 ml and the mixture heated at 1007C for 5
Splenocyte preparationmin and cooled before direct addition to PCR amplifica-
tion reactions. Spleens were aseptically removed and single cell sus-
pensions were obtained by grinding the spleens between
RNA preparation the frosted ends of microscope slides. Erythrocytes were
lysed by 0.83% NH4Cl treatment and intact cells wereFreshly collected tissue was crushed between two
then pelleted and washed twice in medium to removefrosted microscope slides and placed in guanidinium iso-
traces of NH4Cl. LCMV-immune splenocytes were pre-thiocyanate (4.0 M guanidinium thiocyanate, 25 mM so-
pared from adult C57Bl/6 mice immunized 45 days pre-dium citrate, pH 7.0, 0.5% sarkosyl, 0.1 M b-mercaptoeth-
viously with 105 PFU of LCMV-Arm and 1 1 106 cellsanol, and 1 – 2 drops antifoam; Chirgwin et al., 1979). The
were introduced into recipient mice by intraperitonealcell lysates were layered over a 2-ml cushion of cesium
injection.chloride (5.7 M CsCl, 0.1 M EDTA) and centrifuged in a
Beckman ultracentrifuge (SW41 swinging bucket rotor)
Flow cytometryat 30,000 rpm for 16 hr. RNA pellets were resuspended
in sterile TE (10 mM Tris– HCl, pH 7.5, 1 mM EDTA) and Two-color staining was performed by incubating 1 1
106 splenocytes with anti-CD4 or anti-CD11b and anti-ethanol precipitated. mRNA was purified from total cell
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CD8 for 30 min on ice. Directly conjugated antibodies RESULTS
were used: anti-CD4-PE (rat IgG2a), anti-CD8-FITC (rat
Expression cassettes were constructed that placed theIgG2a), and anti-CD11b-PE (rat IgG2b) (Pharmingen, San
LCMV (Armstrong strain) NP cDNA gene adjacent to theDiego, CA). Samples were analyzed on a Becton – Dickin-
mouse metallothionein I promoter (MT-NP, Glanville etson FACScan using Lysis II software.
al., 1981; Fig. 1A) and the LCMV (Armstrong strain) GP-
C cDNA gene adjacent to the SV40 early region promoter
Proliferation assays (SV-GP, Oldstone et al., 1991; Fig. 1B) and DNA-positive
founder mice were generated by microinjection and reim-
Spleen cells were cultured at 1 1 105 cells per well
plantation of fertilized eggs (Hogan et al., 1986). Cross-
in 96-well flat bottom plates in 200 ml RPMI (Biofluids
breeding between singly positive NP and GP-C
Inc., Rockville, MD) with 10% FCS (Hyclone, Logan, UT)
transgenic mice created mice that carried both trans-
in a humidified incubator at 377C with 5% CO2 . Cells were genes (DT mice; Fig. 1C) and the DT mice were subse-
activated either with the T-cell mitogen concanavalin A
quently bred by sequential matings with C57Bl/6 mice.(ConA, 0– 10 mg/ml) or peptides (1 – 10 mM), correspond-
The transgenes were transmitted as unlinked Mendelian
ing to the immunodominant CTL epitopes recognized on
markers and the genotype of all progeny mice was estab-
the H2b background: NP 396– 404 (Schulz et al., 1989;
lished by nucleic acid hybridization and/or PCR amplifi-
Gairin et al., 1995), GP 33-41 (Klavinskis et al., 1990), and
cation.
GP 276– 286 (Oldstone et al., 1988). Human recombinant
Transcription of the NP transgene was detectable by
IL-2 was added at 10 U/ml to control wells to enhance
RT-PCR in brain and kidney but not in spleen or thymus
viability and stimulate proliferation for individual spleno-
and, with the same cDNA preparations from the same
cyte preparations. Cells were pulsed on Day 2 of culture
adult DT mouse tissues, GP-C transcription was detect-
with 1 mCi/well [3H]TdR (Dupont NEN, Boston, MA) and
able in brain, kidney, and spleen but not in thymus (Fig.
harvested the following day for liquid scintillation count-
2). Concurrent RT-PCR amplification of a mouse b-actin
ing. All experimental combinations were performed in
sequence was used to verify that equivalent amounts of
triplicate. Data were analyzed and converted to graphic
tissue-specific cDNA had been used (Fig. 2). The tissueform using Cricket Graph III (Computer Associates Soft-
profile of transgene expression, as defined by RT-PCR,
ware) for the Macintosh with vertical lines representing
was confirmed by Northern blotting and, from this analy-{ standard deviation from the mean.
sis, GP transcription was also detected in lung (data not
shown). RT-PCR amplifications were also performed with
intron-spanning primers, to amplify and sequence a frag-CTL assays
ment containing the splice junction at the 3* end of the
Chromium release assays for CTL activity were per- SV-GP-C mRNA to verify that splicing had occurred cor-
formed largely as described previously (Byrne and Old- rectly (data not shown). However, the absence of an in-
stone, 1984; Oldstone et al., 1988; Whitton et al., 1989). tron in the MT-NP transcription unit precluded the use
CTLs were induced by infecting mice intraperitoneally of intron-spanning primers for independent verification
(i.p.) with 5 1 105 PFU of LCMV ARM and splenocytes of NP transcription.
were collected 4, 7, or 30 days later. To test CTL target We also attempted to document tissue sites of
specificities, 1 1 106 EL4 target cells were simultane- transgene expression using a protocol for syngeneic
ously incubated with 51Cr sodium chromate (Dupont transfer of LCMV-immune splenocytes into transgenic
NEN, Boston, MA) and coated with 1 mM peptide in a recipient mice (Oldstone et al., 1986; Oldstone and South-
humidified incubator at 377C with 5% CO2 for 1 hr. Cells ern, 1993). However, examination of multiple brain and
were then washed 31 in RPMI/10% FCS and 1 1 104 spleen sections from several uninfected recipient
target cells were plated with effector CTLs at E:T ratios transgenic mice failed to reveal extensive histopathologi-
cal damage at Day 7 or Day 14 after the cell transfer.of 50:1 and 25:1 in microtiter plate wells. An equal volume
of complete RPMI 1640 was added in place of effector Occasional minor infiltrates were observed against a
background of largely normal tissue in the kidneys ofcells for measurement of 51Cr spontaneous release, and
100 ml of 2% Triton X-100 was used to record maximum transgenic recipients (Figs. 3A and 3B), suggesting that
the level of transgene expression and/or that the numberrelease. All samples were prepared in triplicate. After
incubation for 6 hr at 377C with 5% CO2 , the plates were of cells expressing the transgene was not sufficiently
high to support large-scale recognition of LCMV determi-centrifuged for 5 min at 3000 rpm, and 100-ml samples
of supernatant were collected and counted on a Gamma nants by the transferred cells. For comparison, extensive
kidney lesions were readily detected in C57Bl/6 mice,5500 instrument (Beckman Instruments, Inc., Palo Alto,
CA). The percentage of specific 51Cr release was calcu- persistently infected with LCMV (Figs. 3C and 3D), even
in the absence of transferred cells, and virus-inducedlated as follows: [(experimental cpm 0 spontaneous re-
lease cpm)/(maximum release cpm 0 spontaneous re- immune complex disease is characteristic of persistent
LCMV infections in adult mice (Oldstone and Dixon, 1970;lease cpm)] 1 100.
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FIG. 1. Construction and characterization of NP and GP-C singly transgenic mice and cross-breeding to produce DT mice. (A) LCMV GP-C
expression cassette containing the SV40 early region promoter, the SV40 small t intron and the SV40 early region polyadenylation site (Oldstone
et al., 1991). (B) LCMV NP expression cassette containing the mouse metallothionein I promoter and polyadenylation site (Glanville et al., 1981).
(C) Detection of LCMV cDNA genes in transgenic mice. Genomic DNA was extracted from a singly transgenic GP-C female mouse, a singly
transgenic NP male mouse, and 6 progeny produced by mating these singly transgenic parents. DNA samples were digested with EcoRI and
fractionated by electrophoresis in a 1% agarose gel. DNA bands within the gel were transferred to a nylon membrane for hybridization with a mixed
probe containing both NP and GP-C labeled sequences. By this assay, progeny 1, 5, and 6 were identified as doubly transgenic (DT) mice, 2 was
GP-C singly transgenic, 4 was NP singly transgenic, and 3 was nontransgenic.
Buchmeier and Oldstone, 1978). We have also noted the areas were found to be equivalent in DT mice and C57Bl/
6 mice at Day 7 post-LCMV infection (data not shown)appearance of cellular infiltrates and mesangial prolifera-
tion within the glomeruli of kidneys from aged, unmanipu- and FACS staining profiles with splenocytes from in-
fected DT and C57Bl/6 mice were virtually indistinguish-lated transgenic mice (mice  1 year old, Figure 3E and
F), but the underlying cause has yet to be defined. able. In particular, relative to uninfected controls,
CD4:CD8 ratios were inverted after infection and thereAcute peripheral LCMV infection of normal adult mice
induces a potent anti-LCMV CTL response and virus is was a characteristic expansion of CD11b/ cells in DT
and C57Bl/6 mice (Table 1), as has been reported pre-rapidly cleared (Marker and Volkert, 1973; Moskophidis
et al., 1987). Paradoxically, the emergence of an anti- viously in acute peripheral LCMV infection of C57Bl/6
mice (McFarland et al., 1992).LCMV CTL response coincides with a generalized tran-
sient immune dysfunction (Jacobs and Cole, 1976), caus- In previous studies with LCMV-transgenic mice, ex-
ogenous peripheral challenge with infectious LCMVing increased susceptibility to secondary infections
(Mims and Wainwright, 1968). This transient immune dys- has been reported to disrupt an immunologically non-
responsive state and anti-LCMV CTLs have been in-function has been measured most effectively by loss of
mitogen responsiveness when splenocytes from infected duced (Oldstone et al., 1991; Ohashi et al., 1991). In
this study, we have exploited the possibility of immuno-mice are stimulated in vitro (Saron et al., 1990; Butz and
Southern, 1994). As we began to search for changes logical nonresponsiveness to both NP and GP-C in the
DT mice to assess whether DT mice would be resistantinduced by exogenous LCMV infection of DT mice, we
examined the responsiveness of splenocytes from to intracerebral (ic) challenge by LCMV. Infection of
normal mice by ic injection with LCMV-Arm (Armstrongacutely infected DT mice to mitogenic stimulation in vitro.
We found that there was a significant reduction in mito- strain) results in an immune-mediated choriomeningi-
tis and the majority (90%) of the infected mice die 6 –gen-driven proliferation for DT mice when splenocytes
harvested from infected mice were compared with con- 9 days postinfection (Rowe, 1954; Hotchin, 1962).
When mice from the DT transgenic breeding colonytrol, uninfected DT splenocytes, and this reduction ex-
actly matched the findings for infected vs uninfected were challenged by ic injection of LCMV-Arm, there
was significant mortality for singly transgenic NP orC57Bl/6 mice. This indicated that the general mecha-
nisms for aberrant activation of splenic T cells, associ- GP-C mice and nontransgenic controls but 33% of the
DT mice survived (Table 2). A lethal outcome for icated with dysregulation between IL-2 and IFN g synthe-
sis (Colle et al., 1993; Ravzi and Welsh, 1993; Butz and challenge of singly-transgenic mice (and non-
transgenic controls) was entirely expected given thatSouthern, 1994), were triggered in both LCMV-infected
C57Bl/6 mice and LCMV-infected DT mice (Fig. 4). the anti-LCMV CTL response induced in H2b mice in-
cludes target epitopes contained within NP and GP-CSplenic enlargement and expansion of the white pulp
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normal appearance and had cleared infectious virus
from the circulation (LCMV plaque assays with plasma
samples, data not shown).
In an attempt to monitor T-cell activation directly in ic-
infected mice, we performed FACs staining with spleno-
cytes harvested from visibly sick mice, at Day 7 postinfec-
tion. The distribution of CD4/, CD8/, and CD11b/ T-cells
was essentially identical for ic-infected C57Bl/6 and DT
mice. Interestingly, ic-infected mice showed only modest
disturbance in CD4:CD8 ratios (CD4:CD8, 1.5:1 unin-
fected and 1:1.3 at Day 7 postinfection) and there were
substantially fewer CD11b/ T-cells relative to the ip-in-
fected mice (8.2– 9.3% CD8/, CD11b/ double-positive
splenocytes in ic-infected mice compared with 22.9 –
29.8% CD8/, CD11b/ double-positive splenocytes in ip-
infected mice, Table 1). It is not clear if the difference
observed in the T-cell content of the spleen reflects al-
tered kinetics of T-cell activation and expansion, as a
consequence of the different doses and routes of infec-
tion, and/or altered distributions of activated lymphocytes
in the infected mice (Allan et al., 1987).
LCMV-specific CTL responses, induced by peripheral
infection of adult DT mice, were identified using in vitro
chromium release assays (Byrne and Oldstone, 1984).FIG. 2. Identification of tissue sites of expression of the LCMV NP or
LCMV-infected targets (H-2b, MC57 cells) were killed byGP-C transgenes by RT-PCR amplification. Total cell RNA preparations
(Chirgwin et al., 1979) were obtained from organs of an adult mouse splenocytes from infected DT mice in an MHC-restricted
that had been treated with Zn2/ to induce metallothionein transcription manner (data not shown), but the epitope specificity for
(Palmiter et al., 1982). Tissue mRNA samples were treated with RNase- CTL recognition could not be inferred from this experi-
free RQ1 DNase (GIBCO) to remove traces of contaminating DNA,
ment because epitopes from both NP and GP-C are pre-prior to initiating reverse transcriptase reactions. PCR products were
sented on the surface of LCMV-infected MC57 cells.analyzed by agarose gel electrophoresis, transferred to a nylon mem-
brane, and then hybridized with LCMV NP or GP-C region-specific Other CTL mapping studies have used vaccinia virus
probes (Southern et al., 1987). Arrows indicate bands of the appropriate recombinants to express individual LCMV cDNA genes,
size to be consistent with the expected products. Note the lack of any or carboxyl-terminal truncations of cDNA genes (Whitton
detectable transgene expression in the thymus. Negative control lanes,
et al., 1988a, b; Schulz et al., 1989), but, in order to exam-where reverse transcriptase was deliberately omitted from the cDNA
ine the responses to the immunodominant NP and GP-synthesis reactions, do not show any LCMV-specific product. This es-
tablished that the observed PCR products were derived from RNA tem- C epitopes directly, we decided to examine CTL recogni-
plates rather than from genomic DNA contamination of the RNA tem- tion of target cells (H2b, EL4 cells) coated with synthetic
plates (von Herrath et al., 1994). (C) Control PCR amplifications with peptides. Previous work has identified the precise se-
b-actin primers to establish equivalence between cDNAs synthesized
quences of peptides spanning the immunodominant CTLfrom the different tissue mRNA preparations.
epitopes within NP and GP-C (Oldstone et al., 1988;
Schulz et al., 1989; Klavinskis et al., 1990; Gairin et al.,
1995) and shown, at least for H2b, that there is no recog-and that recognition of peptide fragments derived from
either protein is sufficient to trigger lethal choriomenin- nition of alternative NP or GP-C epitopes in primary acute
infections of normal mice (von Herrath et al., 1994). Splen-gitis. The intermediate survival frequency (33%) for in-
tracerebrally infected DT mice was determined to be ocytes collected from individual acutely infected DT mice
consistently lysed EL4 target cells coated with NP pep-significant by chi-square analysis with one degree of
freedom and suggested that the combined expression tide (NP 396– 404) but the same preparations of spleno-
cytes failed to lyse EL4 target cells coated with GP pep-of both NP and GP-C transgenes was causing some
alteration in the LCMV-specific CTL response. By mon- tides (GP 33– 41 or GP 276– 286) (Table 3). In contrast,
splenocytes from infected control mice (C57Bl/6 miceitoring mice throughout the course of the acute intrace-
rebral infection, DT mice that would eventually survive or nontransgenic littermates) readily lysed NP- and GP-
coated targets (Table 3). Note that lysis with splenocyteswere observed to display symptoms of LCMV infection
(ruffled fur, hunched posture, and inactivity at some collected from acutely infected C57Bl/6 mice was repro-
ducibly lower with GP 276– 286 coated targets than withpoint in the interval 5– 9 days postinfection), but not to
the same extent as mice that succumbed to LCMV GP 33– 41 coated targets. This may be explained by re-
duced stability for the GP 276– 286 peptide/class I MHCinfection (Hotchin, 1962). By 4 – 5 weeks post-LCMV
infection, the surviving mice had regained an overtly complex, resulting in rapid dissociation of the peptide
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FIG. 3. Histological analysis of kidney sections from transgenic and persistently infected mice (periodic acid-Schiff staining, 3-mm sections). (A)
NP transgenic mouse injected 7 days previously with LCMV immune splenocytes. There is a minor inflammatory cell infiltrate (white arrow) but the
tubules and glomeruli appear normal. Similar infiltrates can be seen occasionally in C57Bl/6 controls (not shown) and in unmanipulated transgenic
mice (E). Magnification 1200. (B) Glomerulus in a transgenic mouse injected 7 days previously with LCMV immune splenocytes. In this field, all
elements are normal. Note the thin basement membrane, the patency of the capillary lumina, and low cellularity in comparison to D. Magnification
1400. (C) Adult C57Bl/6 mouse persistently infected with LCMV from birth. There is a substantial inflammatory cell infiltrate surrounding a small
artery. The glomerulus on the left appears enlarged and both glomeruli in this field show hypercellularity. Magnification 1200. (D) Glomerulus in
an adult C57Bl/6 mouse persistently infected with LCMV from birth. The glomerulus is enlarged and shows accentuation of lobularity. There is
significant thickening of the capillary basement membranes and a distinct increase in cellularity due to mesangiocapillary proliferation and an
inflammatory infiltrate. Note the prominence of the parietal epithelium, narrowing of the Bowman’s space due to enlargement of capillary tufts,
collapse of the capillary lumina, and karyorrhectic debris. Magnification 1400. (E) Unmanipulated aged DT mouse. There is a diffuse inflammatory
cell infiltrate (white arrow) and a relatively normal glomerulus. An area of focal tubular atrophy is indicated by black arrows. Magnification 1200.
(F) Unmanipulated aged DT mouse. This glomerulus is enlarged and shows some accentuation of lobular structure. There is hypercellularity in the
lower left portion of the glomerulus, indicative of mesangial cell proliferation, and an increase in the mesangial matrix. Magnification 1400.
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FIG. 4. Mitogenic activation in vitro with splenocytes from control and acutely infected mice. Splenocytes were prepared from uninfected mice
(A) and mice infected 7 days previously with 1 1 105 PFU LCMV (Armstrong strain) (B) and were plated at 1 1 105 cells per well with increasing
amounts of concanavalin A (ConA, Sigma). After 48 hr in culture, the cells were pulsed with 1 mCi/well [3H]TdR, and harvested the following day
for liquid scintillation counting (Butz and Southern, 1994). The results are shown for individual mice as the mean { standard deviation for triplicate
samples.
from the target cells and/or by lower primary CTL activity same differential proliferative response to NP and GP
peptides in vitro was also found with splenocytes col-directed against the GP 276– 286 epitope (Aichele et al.,
1994). The observation of differential target cell recogni- lected 7 days after ic-infection of DT mice (data not
shown).tion by splenocytes from DT mice suggested that the NP
and GP transgenes may be impacting differently on the There are at least two distinct mechanisms that could
account for the NP-specific CTL response in acutely in-immune responses in acute LCMV infection of DT mice.
This interpretation was confirmed by examining in vitro fected DT mice: (a) the mice have been previously primed
by NP and LCMV challenge is expanding a preexistingproliferative responses to the NP peptide and GP pep-
tides for bulk splenocytes, harvested 7 days after acute NP-specific CTL population or (b) the mice have re-
mained immunologically ignorant of NP and LCMV chal-peripheral infection with LCMV. In the absence of exoge-
nous IL-2, in vitro proliferation of DT splenocytes was lenge induces a conventional primary anti-NP CTL re-
sponse. Preexisting anti-LCMV CTL populations havestimulated by the NP 396– 404 peptide (1 mM), but no
proliferation above background levels was observed in been documented by performing CTL assays with splen-
ocytes harvested at Day 4 of acute LCMV infection, be-response to either of the GP peptides (Table 4). The
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TABLE 1
Flow Cytometric Analysis of Splenocytes Harvested from DT Mice 7 Days after Intraperitoneal LCMV Challenge
Percentage of CD4/ Percentage of CD8/ CD4:CD8 Percentage of CD11b/ Percentage of CD11b/, CD8/
LCMV i.p.
DT (W6) 14.0 48.1 1:3.4 44.4 29.8
DT (W7) 18.9 38.6 1:2.0 38.2 22.9
C57Bl/6 21.9 45.7 1:2.1 39.0 24.7
Uninfected
DT (X2) 16.9 11.3 1.5:1 10.6 1.3
Note. FACS analysis of splenocytes isolated from C57Bl/6 and DT mice 7 days after intraperitoneal infection with LCMV. Cell preparations were
stained with directly conjugated antibodies: anti-CD4-PE, anti-CD11b-PE, and anti-CD8-FITC.
cause, at this time, there is insufficient CTL induction DISCUSSION
from a primary response to obtain effective in vitro killing
Expression of LCMV cDNA genes in transgenic mice cre-(Zarozinski et al., 1995). We were unable to demonstrate
ates a homologous system within which antitransgene im-any CTL recognition above background levels for NP
mune responses can be assessed after exogenous viruspeptide-coated targets with splenocytes from DT mice
challenge with LCMV. In previous studies (Oldstone et al.,at Day 4 of acute LCMV infection, suggesting that preex-
1991; Ohashi et al., 1991, 1993), LCMV infection of transgenicisting NP-specific CTLs were not present. Furthermore,
mice expressing GP from the rat insulin promoter (RIP-GP)CTL recognition of NP could not be uncovered by propa-
led to the induction of anti-LCMV CTL responses that, ingating Day 4 splenocytes in vitro with exogenous IL-2
turn, were responsible for extensive cellular infiltration and(Table 5). Collectively these results indicate that the NP-
damage in the pancreatic islets. Thus, although transgenespecific CTL response in DT mice, observed at Day 7 of
expression may contribute to an initial state of nonrespon-acute LCMV infection, reflects primary immune recogni-
siveness, the emergence of anti-LCMV-specific CTLs sug-tion of the immunodominant NP epitope.
gests that nonresponsiveness was overcome in the face ofWe were also interested to assess whether, by anal-
large antigen load and/or as a consequence of cytokine re-ogy with the mice expressing LCMV transgenes in the
lease during a potent immune response. There is generalpancreas (Oldstone et al., 1991; Ohashi et al., 1991,
support for this latter mechanism because transgenic mice1993), it would be possible to detect emergence of anti-
expressing both LCMV NP and g IFN cDNA genes in theLCMV CTL responses after recovery from acute periph-
islets, developed anti-NP CTL reactivity spontaneously (Leeeral infection. When splenocytes were collected at Day
et al., 1995).30 postinfection, there was evidence for NP-specific CTL
Expression of an LCMV NP transgene in the thymusactivity but there was variability in background levels
resulted in nonresponsiveness to the immunodominantof nonspecific killing in these assays (data not shown).
CTL epitopes, because specific clones were eliminatedHowever, when these same splenocyte preparations
by clonal deletion, but CTLs with reduced affinity for alter-were cultured with IL-2 in vitro and then retested in CTL
native epitopes were generated (von Herrath et al., 1994).assays, there was convincing lysis of NP-coated targets
In experiments reported here, an MT-NP transgene didand the continued absence of lysis with GP-coated tar-
not appear to cause any alteration in anti-NP CTL re-gets (Table 5).
sponses following acute LCMV infection. Although the
NP transgene was transcribed, the failure to induce non-
TABLE 2 responsiveness may indicate that the levels and/or the
sites of expression were inappropriate to cause immuneIntracerebral LCMV Challenge of Transgenic Mice
alteration (Oehen et al., 1994; Kundig et al., 1995). In
Genotype contrast, the SV-GP transgene did induce GP nonrespon-
Number Number Percentage siveness that was not disrupted by exogenous LCMV
NP GP Description infected surviving of survival infection. Both NP and GP transgenes were expressed
at similar low levels in brain and kidney and no expres-/ / DT 30 10 33
sion could be detected in the thymus of adult DT mice,/ 0 NP tg 33 4 12
0 / GP tg 23 1 4 but the critical difference may be explained by GP ex-
0 0 Non-tg 23 2 9 pression in the spleen. In terms of priming an immune
response in adult mice, direct splenic inoculation is
Note. Adult mice were infected by intracerebral injection of 100 PFU known to be highly effective with low concentrations ofof LCMV ARM. A Chi-square analysis with 1 degree of freedom showed
antigen (Kundig et al., 1995). Conversely, presentation ofthat 33% survival was statistically significant. Survival of C57Bl/6 mice
after intracerebral infection with LCMV is less than 5%. endogenous antigen in the spleen is capable of inducing
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TABLE 3 Intracerebral inoculation of LCMV into normal adult
mice results in an immune-mediated choriomeningitisCTL Responses to LCMV in LCMV Transgenic Mice
and90% of the mice die 6– 9 days after infection (Rowe,
Specific 51Cr released (%) from 1954; Hotchin, 1962). An intermediate survival frequency
peptide coated EL4 targets (33%, Table 2) for ic-infected adult DT mice was not antici-
pated and indicates a delicate balance between LCMV-
Source of Day 7 E:T NP GP GP induced immune activation triggering immunopathologyprimary splenic CTL ratio 396 33 276 Ld
or facilitating virus clearance from the CNS. LCMV-spe-
Non-tg 50:1 78 71 24 7 cific CTL recognize epitopes contained within both NP
25:1 59 51 14 3 and GP-C on the H2b background in normal mice,
Non-tg 50:1 59 60 7 3 whereas only a single immunodominant epitope in NP
25:1 36 45 2 3
is recognized by H2d mice. Thus, in adult H2d mice, pre-Non-tg 50:1 51 53 5 2
sentation of an NP epitope is seemingly sufficient to25:1 33 37 1 1
DT (J4) 50:1 65 7 2 3 ensure a lethal outcome to ic-LCMV infection but the
25:1 44 2 3 2 results in this study document 33% survival when anti-
DT (J6) 50:1 58 7 1 2 LCMV-specific CTL are targeted to NP in H2b DT mice.
25:1 37 0 0 2
Collectively, these findings suggest that quantitative and/DT (K1) 50:1 57 8 0 3
or qualitative differences may exist in the anti-NP CTL25:1 35 7 0 2
DT (L2) 50:1 43 16 0 4 response in H2d and H2b mice. This comparison between
25:1 25 6 0 2 H2d and H2b mice is unfortunately not exact because
DT (L3) 50:1 42 18 3 5 different NP peptides are presented by H2d and H2b mice
25:1 16 5 0 2
but it is also possible that genetic differences betweenNP tg (K6) 50:1 48 54 9 1
mouse strains may contribute toward the prospects for25:1 23 27 3 1
GP tg (K7) 50:1 58 9 0 2 survival following LCMV ic challenge. Our data may also
25:1 52 7 0 2 be interpreted to suggest that CTL induction and activity
Uninfected may be influenced by subtle variation within a given MHC
DT 50:1 0 0 0 0 background. According to the breeding program we have
25:1 0 0 0 0 maintained, DT mice and GP-singly transgenic mice
Non-tg 50:1 0 0 0 0 should be genetically identical except for the presence
25:1 0 0 0 0
or absence of the NP transgene locus and both sub-Gp tg (K3) 50:1 0 0 0 2
strains of mice are fully nonresponsive to LCMV-GP. TheNp tg (K4) 50:1 0 0 0 8
results of the ic challenge experiments revealed that DT
Note. Splenocytes were harvested 7 days after i.p. infection with 1 1
105 PFU of LCMV. Effector cells at effector to target (E:T) ratios of 50:1
and 25:1 were used. EL4 target cells (H2b mouse thymoma cell line) were TABLE 4
labeled with 51Cr and pulsed for 1 hr with 1 mM of the indicated peptide.
Ld is the synthetic peptide corresponding to the immunodominant region Stimulation Indices for Peptide Proliferation Assays
of LCMV NP recognized by CD8/ CTLs in H2d mice and was used here
as an irrelevant peptide control. Values represent the mean of triplicate Stimulation index
determinations with variance less than 10%. Similar results were obtained
with four additional infected DT mice. NP 396 GP 33 GP 276 IL2
Non-tg 6.3 7.0 5.7 330.4
DT (A1) 4.8 1.5 1 212.5peripheral nonresponsiveness (Webb et al., 1990; Mon-
DT (A3) 3.0 1.1 1.5 251.5dino et al., 1996; Finkelman et al., 1996) and this mecha-
DT (B4) 4.5 1.3 1.5 274.7nism could account for the absence of GP-specific CTL
Non-tg uninfected 1 1 1 nd
responses in LCMV-infected DT mice. Further insight
may be provided by revisiting the syngeneic immune cell Note. Splenocytes were harvested at Day 7 post-LCMV infection
(i.p.), plated at 1 1 105 cells per well, and cultured with 1 mM LCMVtransfer system to monitor the fate, both physically and
peptide. Cultures were pulsed on Day 2 with 1 mCi/well [3H]TdR, incu-functionally, of LCMV GP-specific T-cells/splenocytes
bated overnight, and harvested for liquid scintillation counting. Stimula-that are transferred into DT recipients. Additionally, it
tion index for proliferative response of individual mice to specific pep-
would be of considerable interest to determine whether tide: (avg cpm of splenocyte cultures from individual mice stimulated
splenectomized DT mice retained their nonrespon- with the indicated LCMV peptide)/(avg cpm of duplicate splenocyte
cultures stimulated with MHC mismatched peptide Ld). Stimulation in-siveness to GP-C following LCMV infection. We have
dex for proliferative response of individual mice to IL2: (avg cpm ofattempted to identify the cellular site(s) of GP expression
splenocyte cultures from individual mice stimulated with 10U/ml IL2)/in the spleen using immunocytochemical staining of
(avg cpm of duplicate splenocyte cultures stimulated with MHC-mis-spleen sections or cytospin preparations of enriched de- matched peptide Ld). Standard error was calculated from the mean of
ndritic cell populations but could not obtain consistent triplicate samples. Similar results were obtained with two additional
i.p.-infected DT mice in an independent repetition of this experiment.positive results (data not shown).
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tion of histology slides, and Dr. Michael B. A. Oldstone and Dr. MatthiasTABLE 5
von Herrath for critical reviews of this manuscript. These experiments
CTL Responses to LCMV in LCMV Transgenic Mice were initiated in Dr. Michael B. A. Oldstone’s laboratory at The Scripps
Research Institute and his interest and insight are gratefully acknowl-
Source of Day 4 Specific 51Cr (%) released edged. Support was provided in part by Public Health Service Grants
splenic CTL from peptide coated EL4 targets NS12428 and AG04342 (M.B.A.O. and P.J.S.) and AI25224 (P.J.S.) and
stimulated in by the University of Minnesota Graduate School Grant-in-Aid Program
vitro with E:T NP GP GP (P.J.S.). J.C.Z. received partial support as a predoctoral fellow from
10U/ml IL2 ratio 396 33 276 Public Health Service Training Grant CA09138.
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